Core Insights - High-rolling investors are taking a bearish position on Alcoa (NYSE:AA), indicating potential insider knowledge or market sentiment shifts [1] - The sentiment among major traders is predominantly bearish, with 63% of options identified being bearish compared to 26% bullish [2] Options Activity - A total of 19 options trades for Alcoa were identified, with one put option valued at $29,875 and 18 call options totaling $2,321,041 [2] - The significant volume and open interest suggest that major players are targeting a price range for Alcoa between $35.0 and $70.0 over the past quarter [3][4] Recent Trading Metrics - The trading volume for Alcoa stands at 4,894,144, with the stock price currently at $58.2, reflecting a 1.5% increase [10] - Analysts have provided an average target price of $62.25 for Alcoa, with varying ratings from different firms, including a downgrade from Morgan Stanley to Equal-Weight with a target of $64 and a downgrade from JP Morgan to Underweight with a target of $50 [9][10] Company Overview - Alcoa is a vertically integrated aluminum company, recognized as the world's largest bauxite miner and alumina refiner by production volume, and the eighth-largest aluminum producer [8] - The company has a historical significance as the first mass producer of aluminum and has undergone strategic changes, including the spin-off of its automotive and aerospace segment in 2016 [8]

UnitedHealth Group Inc (NYSE:UNH) stock is eyeing its worst single-day percentage loss since April, last seen down 19.8% to trade at $281.96. The company posted mixed fourth-quarter earnings results, with profits of $2.11 beating estimates by one cent, while revenue of $113.2 billion came in below expectations. The Centers for Medicare & Medicaid Services proposal to raise Medicare Advantage rates by 0.09% -- far below expectations of a 4-6% increase -- is weighing on the shares, as well as UnitedHealth's s ...

Company Overview - Northrop Grumman is a diversified defense contractor involved in aeronautics, defense, and space systems, producing autonomous and piloted aircraft, missile systems, and various radar and communication systems [8] Options Trading Analysis - Recent options trading for Northrop Grumman shows a bullish sentiment with 52% of traders being bullish and 23% bearish, indicating strong interest in the stock [1] - The total volume of options trades was 1,479, with a mean open interest of 179.62, suggesting significant liquidity in the options market [3] - The price window for Northrop Grumman's options has been identified between $400.0 and $700.0 over the past quarter, reflecting the expectations of major players [2] Recent Market Performance - Northrop Grumman's stock price is currently at $678.32, up 2.62%, with a volume of 889,124 shares traded [10] - Analysts have issued a consensus target price of $705.0, with individual ratings ranging from a Buy rating with a target of $777 from UBS to a Hold rating with a target of $623 from Truist Securities [9][10][11] Notable Options Activity - Significant options trades include bullish call sweeps and puts, with notable trades valued at $136.5K for puts at a strike price of $700.00 and $122.6K for calls at a strike price of $580.00 [7]

Group 1 - American Airlines Group Inc reported fourth-quarter earnings of 16 cents per share and revenue of $14 billion, both of which missed estimates, leading to a 2.2% decline in shares to $14.25 [1] - The company projects strong revenue growth in 2026, expecting to earn 7% to 10% more in the first quarter of this year compared to the same period last year [1] - Year over year, the equity is down 28.5%, with shares slipping since reaching a peak of $16.50 on January 7 [2] Group 2 - In the options market, call options are being traded at double the average pace, with the January 15, 2027 12-strike call being the most active contract [3] - The Schaeffer's Volatility Index (SVI) for the stock is at 49%, ranking in the 18th percentile of its annual range, indicating that options are currently affordable [4] - The stock's Schaeffer's Volatility Scorecard (SVS) is high at 89 out of 100, suggesting that it has exceeded option traders' volatility expectations over the past year [4]

Back to Market on Close. Taking a look at General Motors ahead of Tuesday morning's fourth quarter earnings report. Analysts are expecting adjusted EPS of $2.20%, which would be a 15% increase from last year on revenue of 45.4% billion.That would represent a 5% drop from the prior year. The stock did hit a 25-year high earlier this month and is up nearly 50% over the past 52 weeks. Of course, that makes it the subject of today's Options Corner.Joining us today, Alex Coffee, the co-host of NextGen Investing ...

Core Insights - Investors are taking a bearish stance on Freeport-McMoRan (NYSE:FCX), with significant options trades indicating potential market movements [1][2] - The overall sentiment among large investors is mixed, with 42% bullish and 46% bearish positions [2] - Major market movers are focusing on a price range between $30.0 and $90.0 for Freeport-McMoRan over the last three months [3] Options Trading Analysis - A total of 101 uncommon options trades were detected for Freeport-McMoRan, with 8 puts totaling $1,019,152 and 93 calls totaling $11,094,907 [2] - The analysis of volume and open interest reveals significant liquidity and investor interest in Freeport-McMoRan's options, particularly within the $30.0 to $90.0 strike price range over the past 30 days [4] Company Overview - Freeport-McMoRan owns stakes in 10 copper mines, including a 49% stake in the Grasberg operations in Indonesia and a 55% stake in the Cerro Verde mine in Peru [8] - The company sold approximately 1.2 million metric tons of copper in 2024, making it one of the largest copper miners globally, along with 900,000 ounces of gold and 70 million pounds of molybdenum [8] - Freeport-McMoRan has about 25 years of copper reserves as of December 2024, with expectations of similar copper sales midcycle in 2029, although gold volumes are projected to decline [8] Current Market Position - The current trading volume for Freeport-McMoRan stands at 23,999,005, with the stock price at $61.64, reflecting a 2.04% increase [11] - Analysts have varying ratings, with an average target price of $64.6 from five experts, while individual targets range from $54 to $70 [10][13]

Core Insights - Financial giants are showing a bullish sentiment towards Bristol-Myers Squibb, with 44% of traders being bullish and 33% bearish in recent options trading [1] - Significant investors are targeting a price range of $45.0 to $57.5 for Bristol-Myers Squibb over the past three months [2] - The trading volume for Bristol-Myers Squibb stands at 3,924,289, with the stock price at $54.99, reflecting a 0.63% increase [10] Options Trading Analysis - A total of 9 unusual trades were identified, with 3 puts valued at $105,215 and 6 calls valued at $249,315 [1] - The largest options trades include a bearish call sweep at a strike price of $57.50, valued at $76.7K, and a bearish put sweep at the same strike price, valued at $50.2K [6] - The volume and open interest metrics indicate liquidity and investor interest in options trading for Bristol-Myers Squibb, particularly within the strike price range of $45.0 to $57.5 over the last 30 days [3] Company Overview - Bristol-Myers Squibb focuses on discovering, developing, and marketing drugs for various therapeutic areas, with a strong emphasis on immuno-oncology [7] - Approximately 70% of Bristol-Myers Squibb's total sales are derived from the US market, indicating a higher dependence on the US compared to its peers [7] Analyst Ratings and Price Targets - Recent expert ratings suggest an average target price of $59.5 for Bristol-Myers Squibb, with individual targets ranging from $53 to $65 [9][10] - Analysts from various firms maintain differing ratings, with one upgrading to Buy and setting a price target of $65, while others maintain Neutral and Outperform ratings [10][11]

Core Insights - American Airlines Group (NASDAQ:AAL) has seen significant options trading activity, with over 8 trades totaling $551,694 detected by Benzinga's options scanner [1] - Whales have targeted a price range for American Airlines Group between $13.0 and $20.0 over the last 3 months, indicating investor sentiment and potential price movements [2] - The volume and open interest metrics for American Airlines Group's options provide insights into liquidity and investor interest, particularly within the strike price range of $13.0 to $20.0 over the past 30 days [3] Options Activity - Noteworthy options trades include bullish sentiment on both put and call options, with significant trades such as a $187,000 put option at a strike price of $14.00 expiring on May 15, 2026, and a $136,500 call option at a strike price of $14.50 expiring on January 30, 2026 [6] - The total trade volume for American Airlines Group options reflects a mix of bullish and neutral sentiments, with varying strike prices and expiration dates [6] Market Position - American Airlines Group is the largest airline globally by aircraft and capacity, generating over 30% of US airline revenue by connecting Latin America with the US [7] - Analysts have set an average price target of $18.6 for American Airlines Group, with individual targets ranging from $16 to $21 from various analysts [8][9][10] - The current trading price of AAL is $14.62, reflecting a slight decrease of -0.37%, with upcoming earnings reports expected to influence market sentiment [9]

Whales with a lot of money to spend have taken a noticeably bearish stance on Zoom Communications.Looking at options history for Zoom Communications (NASDAQ:ZM) we detected 70 trades.If we consider the specifics of each trade, it is accurate to state that 34% of the investors opened trades with bullish expectations and 50% with bearish.From the overall spotted trades, 15 are puts, for a total amount of $703,460 and 55, calls, for a total amount of $3,271,488.Expected Price MovementsTaking into account the V ...

Company Overview - Moderna is a commercial-stage biotech founded in 2010, with its IPO in December 2018. The company's mRNA technology gained rapid validation through its COVID-19 vaccine, authorized in the U.S. in December 2020. As of August 2025, Moderna has 35 mRNA development candidates in clinical studies across various therapeutic areas, including infectious diseases, oncology, cardiovascular diseases, and rare genetic diseases [8]. Market Sentiment - Recent options trading indicates a bearish sentiment among deep-pocketed investors towards Moderna, with 55% of notable options leaning bearish and only 33% bullish. This shift in sentiment is significant and suggests that market players should pay attention [1][2]. - The total options activity for Moderna has been extraordinary, with 12 put options totaling $1,840,896 and 6 call options amounting to $311,479 [2]. Price Targets and Trading Activity - Whales have been targeting a price range for Moderna between $30.0 and $50.0 over the last three months, based on the volume and open interest of options contracts [3]. - The average open interest for Moderna options is 531.31, with a total trading volume of 9,720.00. The trading activity has been concentrated within the strike price corridor of $30.0 to $50.0 over the past 30 days [4]. Recent Trading Data - Significant options trades include bearish put options with a total trade value of $1.1 million at a strike price of $42.00, and bullish put options valued at $300,000 with a strike price of $47.00. Additionally, there are neutral and bearish call options with varying trade values and strike prices [7]. Current Market Standing - As of the latest data, Moderna's trading volume is 3,713,575, with the stock price down by 2.71% at $47.39. Analysts have recently adjusted their ratings, with one expert from UBS revising the price target down to $34.0, indicating a neutral stance on the stock [10][11].